Skip to main content
Top
Published in: Infectious Diseases and Therapy 3/2020

Open Access 01-09-2020 | Ampicillin | Review

Guideline Recommendations for Empirical Antimicrobial Therapy: An Appraisal of Research Evidence for Clinical Decision-Making in Ethiopia

Authors: Balew Arega, Asnake Agunie, Abraham Minda, Amdemeskel Mersha, Alazar Sitotaw, Getachew Weldeyohhans, Ayele Teshome, Kelemework Adane, Getachew Mengistu

Published in: Infectious Diseases and Therapy | Issue 3/2020

Login to get access

Abstract

Introduction

The rapid spread of drug resistance is forcing standard treatment guidelines (STGs) to become more appropriate with due consideration of the evidence on the antimicrobial resistance (AMR) situation in Ethiopia. Therefore, we aimed to assess the local AMR recommendations in the STGs for empirical antibacterial prescriptions for the five common infectious syndromes. We also determined the quality of AMR reviews conducted in the country.

Methods

We conducted a review of the STGs used in the health centers, general hospitals, and primary hospitals in Ethiopia and assessed the AMR recommendations in STGs for empirical antibacterial prescriptions for community-acquired pneumonia (CAP), urinary tract infection (UTI), tonsillopharyngitis, acute otitis media (AOM), and bacterial dysentery. Next, we performed an overview of AMR reviews published in Ethiopia. We used the MEDLINE/PubMed, Embase, Cochrane Library, and Google Scholar databases to identify AMR reviews. The review characteristics were extracted. We also evaluated the quality of each included AMR review using a measurement tool to assess the systematic review scale (AMSTAR 2).

Results

A total of 6 STGs and 12 AMR reviews conducted in the country were included. The choice of empirical antibacterials for similar infectious syndromes (and editions) was comparable across the three levels of the health care system. None of the STGs evaluated included the local AMR recommendations for empirical antibacterial prescriptions for five common infectious syndromes. Of all the AMR reviews included, 75% had low and below methodologic quality, and none had a high-quality score using the AMSTAR 2 tool.

Conclusion

Standard treatment guidelines did not consider local AMR recommendations for empirically prescribing antibacterials for common infectious syndromes. The AMR reviews published in the country produced poor methodologic quality evidence for clinical applications. This highlights the need to improve the methodologic quality to provide the best available evidence for clinical decision-making and curb the ongoing AMR in Ethiopia.

Trial registration

Retrospectively registered (15/07/2020).
Appendix
Available only for authorised users
Literature
1.
go back to reference Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(2):S82.CrossRef Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(2):S82.CrossRef
2.
go back to reference Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47.CrossRef Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6:47.CrossRef
3.
go back to reference Aseffa A, Abate E, Seyoum B, et al. Investigations on antimicrobial resistance: contributions of a clinical research network. Ethiop Med J. 2019;1:3–7. Aseffa A, Abate E, Seyoum B, et al. Investigations on antimicrobial resistance: contributions of a clinical research network. Ethiop Med J. 2019;1:3–7.
4.
go back to reference Yusuf E, Ong DS, Martin-Quiros A, et al. A large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and suggesting improvements. Eur J Clin Microbiol Infect Dis. 2017;36:233–42.CrossRef Yusuf E, Ong DS, Martin-Quiros A, et al. A large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and suggesting improvements. Eur J Clin Microbiol Infect Dis. 2017;36:233–42.CrossRef
5.
go back to reference Elias C, Moja L, Mertz D, et al. Guideline recommendations and antimicrobial resistance: the need for a change. BMJ Open. 2017;7:e016264.CrossRef Elias C, Moja L, Mertz D, et al. Guideline recommendations and antimicrobial resistance: the need for a change. BMJ Open. 2017;7:e016264.CrossRef
6.
go back to reference WHO. WHO handbook for guideline development.2012. WHO. WHO handbook for guideline development.2012.
7.
go back to reference Prorok JC, Iserman EC, Wilczynski NL, et al. The quality, breadth, and timeliness of content updating vary substantially for 10 online medical texts: an analytic survey. J Clin Epidemiol. 2012;65:1289–95.CrossRef Prorok JC, Iserman EC, Wilczynski NL, et al. The quality, breadth, and timeliness of content updating vary substantially for 10 online medical texts: an analytic survey. J Clin Epidemiol. 2012;65:1289–95.CrossRef
9.
go back to reference Ibrahim RA, Amete M. Antimicrobial resistance surveillance in Ethiopia: implementation experiences and lessons learned and Wubshet M. KefichoAfr. J Lab Med. 2019;8(1):1109. Ibrahim RA, Amete M. Antimicrobial resistance surveillance in Ethiopia: implementation experiences and lessons learned and Wubshet M. KefichoAfr. J Lab Med. 2019;8(1):1109.
10.
go back to reference Food, Medicine, and Health Care Administration and Control Authority. Standard Treatment Guideline for health centers. Third Edition, 2010 Food, Medicine, and Health Care Administration and Control Authority. Standard Treatment Guideline for health centers. Third Edition, 2010
12.
go back to reference Food, Medicine, and Health Care Administration and Control Authority. Standard treatment guideline for health cenetrs. Addis Ababa: Food, Medicine, and Health Care Administration and Control Authority; 2014. Food, Medicine, and Health Care Administration and Control Authority. Standard treatment guideline for health cenetrs. Addis Ababa: Food, Medicine, and Health Care Administration and Control Authority; 2014.
13.
go back to reference Food, Medicine, and Health Care Administration and Control Authority. Standard treatment guidelines for primary hospitals. Addis Ababa: Food, Medicine, and Health Care Administration and Control Authority; 2010. Food, Medicine, and Health Care Administration and Control Authority. Standard treatment guidelines for primary  hospitals. Addis Ababa: Food, Medicine, and Health Care Administration and Control Authority; 2010.
14.
go back to reference Food, Medicine, and Health Care Administration and Control Authority. Standard treatment guidelines for primary hospitals. Addis Ababa: Food, Medicine, and Health Care Administration and Control Authority; 2014. Food, Medicine, and Health Care Administration and Control Authority. Standard treatment guidelines for primary hospitals. Addis Ababa: Food, Medicine, and Health Care Administration and Control Authority; 2014.
15.
go back to reference Food, Medicine, and Health care Administration and control authority. Standard treatment guidelines for general hospitals. Third Edition, 2010. Food, Medicine, and Health care Administration and control authority. Standard treatment guidelines for general hospitals. Third Edition, 2010.
16.
go back to reference Food, Medicine, and Health care Administration and control authority. Standard treatment guidelines for general hospitals. Third Edition, 2014. Food, Medicine, and Health care Administration and control authority. Standard treatment guidelines for general hospitals. Third Edition, 2014.
17.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the Prisma statement. PLoS Med. 2009;6(6):e1000097. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the Prisma statement. PLoS Med. 2009;6(6):e1000097.
18.
go back to reference Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions, or both. BMJ. 2017;21:358:j4008. Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions, or both. BMJ. 2017;21:358:j4008.
19.
go back to reference Tadesse G. A meta-analysis of the proportion of antimicrobial resistant human Salmonella isolates in Ethiopia. BMC Pharmacol Toxicol. 2014;15:51.CrossRef Tadesse G. A meta-analysis of the proportion of antimicrobial resistant human Salmonella isolates in Ethiopia. BMC Pharmacol Toxicol. 2014;15:51.CrossRef
20.
go back to reference Deyno S, SintayehuFekadu S, Seyfe S. Prevalence and antimicrobial resistance of coagulase-negative staphylococci clinical isolates from Ethiopia: a meta-analysis. BMC Microbiol. 2018;18:43.CrossRef Deyno S, SintayehuFekadu S, Seyfe S. Prevalence and antimicrobial resistance of coagulase-negative staphylococci clinical isolates from Ethiopia: a meta-analysis. BMC Microbiol. 2018;18:43.CrossRef
21.
go back to reference Eshetie S, Tarekegn F, Moges F. Methicillin-resistant Staphylococcus aureus in Ethiopia: a meta-analysis. BMC Infect Dis. 2016;16:689.CrossRef Eshetie S, Tarekegn F, Moges F. Methicillin-resistant Staphylococcus aureus in Ethiopia: a meta-analysis. BMC Infect Dis. 2016;16:689.CrossRef
22.
go back to reference Hussen S, Mulatu G, Kassa ZY. Prevalence of Shigella species and its drug resistance pattern in Ethiopia: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2019;18:22.CrossRef Hussen S, Mulatu G, Kassa ZY. Prevalence of Shigella species and its drug resistance pattern in Ethiopia: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2019;18:22.CrossRef
23.
go back to reference Sisay M, Weldegebrea F, Tesfa T. Resistance profile of clinically relevant bacterial isolates against fluoroquinolone in Ethiopia: a systematic review and meta-analysis. BMC Pharmacol Toxicol. 2018;19:86.CrossRef Sisay M, Weldegebrea F, Tesfa T. Resistance profile of clinically relevant bacterial isolates against fluoroquinolone in Ethiopia: a systematic review and meta-analysis. BMC Pharmacol Toxicol. 2018;19:86.CrossRef
24.
go back to reference Sisay M, Worku T, Edessa D. Microbial epidemiology and antimicrobial resistance patterns of wound infection in Ethiopia: a meta-analysis of laboratory-based cross-sectional studies. BMC Pharmacol Toxicol. 2019;20:35.CrossRef Sisay M, Worku T, Edessa D. Microbial epidemiology and antimicrobial resistance patterns of wound infection in Ethiopia: a meta-analysis of laboratory-based cross-sectional studies. BMC Pharmacol Toxicol. 2019;20:35.CrossRef
26.
go back to reference Deyno S, Fekadu S, Astatkie A. Resistance of Staphylococcus aureus to antimicrobial agents in Ethiopia: a meta-analysis. Antimicrob Resist Infect Control. 2017;6:85.CrossRef Deyno S, Fekadu S, Astatkie A. Resistance of Staphylococcus aureus to antimicrobial agents in Ethiopia: a meta-analysis. Antimicrob Resist Infect Control. 2017;6:85.CrossRef
28.
go back to reference Reta A, Mengist A, Tesfahun A. Nasal colonization of methicillin-resistant Staphylococcus aureus in Ethiopia: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2019;18:25.CrossRef Reta A, Mengist A, Tesfahun A. Nasal colonization of methicillin-resistant Staphylococcus aureus in Ethiopia: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2019;18:25.CrossRef
30.
go back to reference Beyene G, Asrat D, Mengistu Y. Typhoid fever in Ethiopia. J Infect Dev Ctries. 2008;2(6):448–53.CrossRef Beyene G, Asrat D, Mengistu Y. Typhoid fever in Ethiopia. J Infect Dev Ctries. 2008;2(6):448–53.CrossRef
31.
go back to reference WHO. Report on surveillance of antibiotic consumption. 2016–2018. WHO. Report on surveillance of antibiotic consumption. 2016–2018.
32.
go back to reference Federal democratic republic of Ethiopia ministry of health. Guideline for implementation of a patient referral system. May 2010. Federal democratic republic of Ethiopia ministry of health. Guideline for implementation of a patient referral system. May 2010.
33.
go back to reference WHO. Implementation of the global action plan on antimicrobial resistance. WHO gap AMR;2017. WHO. Implementation of the global action plan on antimicrobial resistance. WHO gap AMR;2017.
34.
go back to reference Gebretekle GB, Haile Mariam D, Abebe W, et al. Opportunities and barriers to implementing antibiotic stewardship in low and middle-income countries: lessons from a mixed-methods study in a tertiary care hospital in Ethiopia. PLoS ONE. 2018;13(12):e0208447.CrossRef Gebretekle GB, Haile Mariam D, Abebe W, et al. Opportunities and barriers to implementing antibiotic stewardship in low and middle-income countries: lessons from a mixed-methods study in a tertiary care hospital in Ethiopia. PLoS ONE. 2018;13(12):e0208447.CrossRef
35.
go back to reference American a cademy of pediatrics.classifying recommendations for clinical practice guidelines. Pediatrics 2004;114(3):874–6. American a cademy of pediatrics.classifying recommendations for clinical practice guidelines. Pediatrics 2004;114(3):874–6.
36.
go back to reference Tesfa B. Challenges of Ethiopian researchers and potential mitigation with Ethiopian science, technology, and innovation policy 2015; Corpus ID: 14798318:1–17. Tesfa B. Challenges of Ethiopian researchers and potential mitigation with Ethiopian science, technology, and innovation policy 2015; Corpus ID: 14798318:1–17.
37.
go back to reference Habtewold TD, Alemu SM, Mohammed SH, et al. Reviews and meta-analyses in Ethiopia had poor methodological quality: an overview of evidence 1970 to 2018. J Clin Epidemiol. 2019;109:90–8.CrossRef Habtewold TD, Alemu SM, Mohammed SH, et al. Reviews and meta-analyses in Ethiopia had poor methodological quality: an overview of evidence 1970 to 2018. J Clin Epidemiol. 2019;109:90–8.CrossRef
38.
go back to reference Vriezen R, Sargeant JM, Vriezen E, Winder CB, O’Connor AM. Quality assessment of systematic reviews and meta-analyses that examine preventive antibiotic uses and management practices designed to prevent disease in livestock. Anim Health Res Rev. 2019;20:305–18.CrossRef Vriezen R, Sargeant JM, Vriezen E, Winder CB, O’Connor AM. Quality assessment of systematic reviews and meta-analyses that examine preventive antibiotic uses and management practices designed to prevent disease in livestock. Anim Health Res Rev. 2019;20:305–18.CrossRef
39.
go back to reference Gaym A. Health research in Ethiopia—past, present, and suggestions on the way forward. Ethiop Med J. 2008;46(3):287–308.PubMed Gaym A. Health research in Ethiopia—past, present, and suggestions on the way forward. Ethiop Med J. 2008;46(3):287–308.PubMed
40.
go back to reference Ampaire L, Muhindo A, Orikiriza P, et al. A review of antimicrobial resistance in East Africa. Afr J Lab Med. 2016;5(1):1–6.CrossRef Ampaire L, Muhindo A, Orikiriza P, et al. A review of antimicrobial resistance in East Africa. Afr J Lab Med. 2016;5(1):1–6.CrossRef
Metadata
Title
Guideline Recommendations for Empirical Antimicrobial Therapy: An Appraisal of Research Evidence for Clinical Decision-Making in Ethiopia
Authors
Balew Arega
Asnake Agunie
Abraham Minda
Amdemeskel Mersha
Alazar Sitotaw
Getachew Weldeyohhans
Ayele Teshome
Kelemework Adane
Getachew Mengistu
Publication date
01-09-2020
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy / Issue 3/2020
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-020-00308-3

Other articles of this Issue 3/2020

Infectious Diseases and Therapy 3/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.